RFA joins arsenal for breast cancer metastases in the liver

Article

In patients for whom surgery is not an option, percutaneous radio-frequency ablation offers a viable alternative for treating breast cancer metastatic disease in the liver.

In patients for whom surgery is not an option, percutaneous radio-frequency ablation offers a viable alternative for treating breast cancer metastatic disease in the liver.

Researchers from 12 centers participating in the tumor radio-frequency ablation Italian network (TRAIN) treated 102 patients with breast cancer, using the ablation technique. Under ultrasound or CT guidance, they applied RFA to tumors ranging from 0.8 to 5 cm in diameter. Results were presented at the 2004 RSNA meeting.

Using the Kaplan-Meier method, the researchers reported survival rates ranging from 95.2% at one year to 29.8% at five years. They completed RFA of tumors in 91.2% of the patients after 121 treatment sessions, and the primary effectiveness rate on a lesion-by-lesion basis was 86.9.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.